JENNIFER WARGO to Microbiota
This is a "connection" page, showing publications JENNIFER WARGO has written about Microbiota.
Connection Strength
5.107
-
The Microbiome in Gastrointestinal Cancers. Gastroenterol Clin North Am. 2022 09; 51(3):667-680.
Score: 0.532
-
AI finds microbial signatures in tumours and blood across cancer types. Nature. 2020 03; 579(7800):502-503.
Score: 0.448
-
The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View. Trends Cancer. 2020 03; 6(3):192-204.
Score: 0.446
-
The Microbiome in Immuno-oncology. Adv Exp Med Biol. 2020; 1244:325-334.
Score: 0.443
-
The Tumor Microbiome in Pancreatic Cancer: Bacteria and Beyond. Cancer Cell. 2019 12 09; 36(6):577-579.
Score: 0.441
-
The cancer microbiome. Nat Rev Cancer. 2019 07; 19(7):371-376.
Score: 0.426
-
The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy. Trends Immunol. 2018 11; 39(11):900-920.
Score: 0.408
-
TARO: tree-aggregated factor regression for microbiome data integration. Bioinformatics. 2024 06 03; 40(6).
Score: 0.150
-
Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell. 2023 11 13; 41(11):1945-1962.e11.
Score: 0.144
-
TIME for Bugs: The Immune Microenvironment and Microbes in Precancer. Cancer Prev Res (Phila). 2023 09 01; 16(9):497-505.
Score: 0.143
-
Young-onset Rectal Cancer: Unique Tumoral Microbiome and Correlation With Response to Neoadjuvant Therapy. Ann Surg. 2023 10 01; 278(4):538-548.
Score: 0.141
-
Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance. Nature. 2023 05; 617(7960):377-385.
Score: 0.139
-
HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development. Front Immunol. 2023; 14:1051431.
Score: 0.138
-
Microbiome influencers of checkpoint blockade-associated toxicity. J Exp Med. 2023 03 06; 220(3).
Score: 0.136
-
Targeting the gut and tumor microbiota in cancer. Nat Med. 2022 04; 28(4):690-703.
Score: 0.130
-
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment. Cell. 2021 10 14; 184(21):5338-5356.e21.
Score: 0.125
-
The microbiome and human cancer. Science. 2021 03 26; 371(6536).
Score: 0.120
-
Can we harness the microbiota to enhance the efficacy of cancer immunotherapy? Nat Rev Immunol. 2020 09; 20(9):522-528.
Score: 0.115
-
The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020 05 29; 368(6494):973-980.
Score: 0.114
-
The microbiome, cancer, and cancer therapy. Nat Med. 2019 03; 25(3):377-388.
Score: 0.104
-
Combination Immunotherapy Development in Melanoma. Am Soc Clin Oncol Educ Book. 2018 May 23; 38:197-207.
Score: 0.099
-
Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy. Front Immunol. 2018; 9:946.
Score: 0.099
-
Embracing cancer complexity: Hallmarks of systemic disease. Cell. 2024 Mar 28; 187(7):1589-1616.
Score: 0.037
-
Considerations for designing preclinical cancer immune nanomedicine studies. Nat Nanotechnol. 2021 01; 16(1):6-15.
Score: 0.030